BCG Infection in Patients With Inborn Errors of Immunity Receiving the Russian BCG Strain

J Allergy Clin Immunol Pract. 2022 Jul;10(7):1797-1804.e7. doi: 10.1016/j.jaip.2022.03.032. Epub 2022 Apr 22.

Abstract

Background: Bacillus Calmette-Guierin (BCG) vaccination complications are common in inborn errors of immunity (IEI) due to the inability to clear live attenuated Mycobacterium bovis. Various BCG-vaccine strains are used worldwide, and the profile of the Russian BCG strain vaccine complications in IEI is poorly characterized.

Objective: To evaluate risks of BCG infection in a large cohort of patients with IEI vaccinated with the Russian BCG strain.

Methods: We evaluated 778 patients with IEI vaccinated with the Russian BCG strain.

Results: A total of 114 (15%) developed BCG infection, 41 (36%) with local, 19 (17%) with regional, and 54 with (47%) disseminated disease. BCG infection was seen in 58% of the patients with severe combined immunodeficiency (SCID), 82% with chronic granulomatous disease, 50% with innate immune defects, 5% with combined immunodeficiency, and 2% with other IEI. BCG infection presented at a median age of 4 to 5 months in SCID, chronic granulomatous disease, combined immunodeficiency, and other IEI groups versus 12 months in patients with innate immune defects (P < .005). We found no influence of specific genetic defects, CD3+ and natural killer cell numbers in SCID, or dihydrorhodamine test stimulation index values in chronic granulomatous disease on the BCG-infection risks. All patients with SCID received antimycobacterial therapy at SCID diagnosis even in the absence of active BCG infection. More antimycobacterial agents were required in disseminated relative to local or regional infection (P < .0001). Only 1 of 114 patients (with SCID) died of BCG-related complications (<1%).

Conclusions: BCG infection is common in patients with IEI receiving BCG vaccination. Rational early antimycobacterial therapy, combined with anticytokine agents for posttransplant inflammatory syndrome prevention, and treatment in SCID may prevent BCG-related mortality.

Keywords: BCG infection; BCG strain; BCGitis; BCGosis; Bacillus Calmette-Guierin; Chronic granulomatous disease; Inborn errors of immunity; Mendelian susceptibility to mycobacterial disorders; Primary immunodeficiency; Severe combined immunodeficiency.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Anti-Bacterial Agents
  • BCG Vaccine / therapeutic use
  • Bacillus*
  • Bacterial Infections* / complications
  • Granulomatous Disease, Chronic* / complications
  • Humans
  • Infant
  • Mycobacterium bovis*
  • Primary Immunodeficiency Diseases*
  • Severe Combined Immunodeficiency* / therapy

Substances

  • Anti-Bacterial Agents
  • BCG Vaccine